Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 1c
February 27, 2025 4:19 PM ESTXenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.84), $0.01 better than the analyst estimate of ($0.85).
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
... More